Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Profit After Tax: 2018-2024

Historic Profit After Tax for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to -$80.9 million.

  • Arcturus Therapeutics Holdings' Profit After Tax fell 94.81% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year decrease of 6.49%. This contributed to the annual value of -$80.9 million for FY2024, which is 172.30% down from last year.
  • Arcturus Therapeutics Holdings' Profit After Tax amounted to -$80.9 million in FY2024, which was down 172.30% from -$29.7 million recorded in FY2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Profit After Tax peaked at $9.3 million during FY2022, and registered a low of -$203.7 million during FY2021.
  • Moreover, its 3-year median value for Profit After Tax was -$29.7 million (2023), whereas its average is -$33.8 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first spiked by 104.59% in 2022, then tumbled by 417.95% in 2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Profit After Tax (Yearly) stood at -$72.1 million in 2020, then crashed by 182.30% to -$203.7 million in 2021, then spiked by 104.59% to $9.3 million in 2022, then crashed by 417.95% to -$29.7 million in 2023, then tumbled by 172.30% to -$80.9 million in 2024.